The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update (30-month) of the pivotal ERIVANCE BCC study.
Aleksandar Sekulic
Consultant or Advisory Role - Roche/Genentech (U)
Michael Robert Migden
Consultant or Advisory Role - Roche/Genentech
Honoraria - Genentech; Lilly; Novartis
Research Funding - Genentech
Expert Testimony - Novartis (U)
Other Remuneration - Roche/Genentech
Nicole Basset-Seguin
Consultant or Advisory Role - Roche
Honoraria - Roche
Claus Garbe
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Anja Gesierich
Honoraria - Roche
Other Remuneration - Roche
Christopher Lao
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Chris Miller
No relevant relationships to disclose
Laurent Mortier
Consultant or Advisory Role - Roche
Honoraria - Roche
Dedee F. Murrell
Consultant or Advisory Role - Roche
Research Funding - Roche
Omid Hamid
Consultant or Advisory Role - Genentech (U)
Honoraria - Genentech
Research Funding - Genentech
Fernando Quevedo
No relevant relationships to disclose
Jeannie Hou
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Mukta Tripathi
Consultant or Advisory Role - Genentech
Dirk Schadendorf
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche
Research Funding - Merck